Minimal residual disease monitored after induction therapy by RQ-PCR can contribute to tailor treatment of patients with t(8;21) RUNX1-RUNX1T1 rearrangement.
Haematologica
; 100(3): e99-101, 2015 Mar.
Article
in En
| MEDLINE
| ID: mdl-25480496
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Transcription Factors
/
Chromosomes, Human, Pair 8
/
Chromosomes, Human, Pair 21
/
Leukemia, Myeloid, Acute
/
Biomarkers, Tumor
/
Proto-Oncogene Proteins
/
Core Binding Factor Alpha 2 Subunit
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
Limits:
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
/
Newborn
Language:
En
Journal:
Haematologica
Year:
2015
Document type:
Article